Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2,3,4 and 5.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Endocrinology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/en.139.2.807PMID 9449659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells.

  1997cited by this paper
• Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism*

  1997cited by this paper
• Androgen deprivation as a strategy for prostate cancer chemoprevention.

  1997cited by this paper
• Growth inhibition by insulin-like growth factor (IGF) binding protein-3--what's IGF got to do with it?

  1997cited by this paper
• The role of insulin-like growth factors in prostate biology.

  1996cited by this paper
• Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.

  1996cited by this paper
• Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780.

  1996cited by this paper
• Endocrine control of prostate cancer.

  1995cited by this paper
• The insulin-like growth factor I receptor: a key to tumor growth?

  1995cited by this paper
• Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action.

  1995cited by this paper
• The role of growth factors in the suppression of active cell death in the prostate: an hypothesis.

  1994cited by this paper
• Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients.

  1993cited by this paper
• Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780.

  1993cited by this paper
• Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells.

  1993cited by this paper
• Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition.

  1993cited by this paper
• Genomic organization and expression of the rat TRPM-2 (clusterin) gene, a gene implicated in apoptosis.

  1993cited by this paper
• Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen.

  1993cited by this paper
• Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5 alpha-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels.

  1993cited by this paper
• Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells.

  1991cited by this paper
• Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death.

  1989cited by this paper
• Activation of programmed cell death in the rat ventral prostate after castration.

  1988cited by this paper
• Identification, characterization, and regulation of a rat complementary deoxyribonucleic acid which encodes insulin-like growth factor-I.

  1987cited by this paper

• Insulin-like growth factor family and prostate cancer: new insights and emerging opportunities

  2024cites this paper
• Changes in hepato-renal gene expression in microminipigs following a single exposure to a mixture of perfluoroalkyl acids

  2019cites this paper
• Functional and structural changes in internal pudendal arteries underlie erectile dysfunction induced by androgen deprivation

  2016cites this paper
• Identification of Differentially Expressed IGFBP5-Related Genes in Breast Cancer Tumor Tissues Using cDNA Microarray Experiments

  2015cites this paper
• Pappa2 deletion in mice affects male but not female fertility

  2015cites this paper
• Control of IGFBP-2 Expression by Steroids and Peptide Hormones in Vertebrates

  2014cites this paper
• Critical role of insulin-like growth factor binding protein-5 in methamphetamine-induced apoptosis in cardiomyocytes

  2014influential citation
• Insulin-like growth factor binding protein 5 (IGFBP5) mediates methamphetamine-induced dopaminergic neuron apoptosis.

  2014cites this paper
• Inhibition of the Insulin-Like Growth Factor-1 Receptor Enhances Effects of Simvastatin on Prostate Cancer Cells in Co-Culture with Bone

  2013cites this paper
• Prostate Cancer

  2013cites this paper
• Rational Categorization of the Pipeline of New Treatments for Advanced Cancer – Prostate Cancer as an Example

  2013cites this paper
• Role of interleukins, IGF and stem cells in BPH.

  2011cites this paper
• Effect of dexamethasone and testosterone treatment on the regulation of insulin‐degrading enzyme and cellular changes in ventral rat prostate after castration

  2011cites this paper
• Local insulin-like growth factor-I of ventral prostate was upregulated during long-term castration and may function through the autocrine system

  2011cites this paper
• Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.

  2009cites this paper
• Lycopene in Cancer Prevention and Treatment

  2008cites this paper
• An Antibody Targeting the Type I Insulin-like Growth Factor Receptor Enhances the Castration-Induced Response in Androgen-Dependent Prostate Cancer

  2007cites this paper
• The Relationship of Clusterin Expression with Ki-67 Expression and Clinicopathological Factors in Human Renal Cell Carcinoma

  2007cites this paper
• Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis.

  2007cites this paper
• Lycopene and Soy Isoflavones in the Treatment of Prostate Cancer

  2007cites this paper
• Time-dependent rescue of gene expression by androgens in the mouse proximal caput epididymidis-1 cell line after androgen withdrawal.

  2007cites this paper
• Regulation of global gene expression in the bone marrow microenvironment by androgen: Androgen ablation increases insulin‐like growth factor binding protein‐5 expression

  2007cites this paper
• Differential regulation of IGFBP‐3 by the androgen receptor in the lineage‐related androgen‐dependent LNCaP and androgen‐independent C4‐2 prostate cancer models

  2006cites this paper
• Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis.

  2006cites this paper
• Clusterin Expression and Univariate Analysis of Overall Survival in Human Breast Cancer

  2006cites this paper
• Insulin-Like Growth Factor (IGF) family and prostate cancer.

  2006cites this paper
• SOM230 inhibits insulin-like growth factor-I action in mammary gland development by pituitary independent mechanism: mediated through somatostatin subtype receptor 3?

  2006cites this paper
• Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence?

  2006cites this paper
• High expression of insulin-like growth factor binding protein–2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels

  2006cites this paper
• PANDER-induced cell-death genetic networks in islets reveal central role for caspase-3 and cyclin-dependent kinase inhibitor 1A (p21).

  2006cites this paper
• Castration rapidly decreases local insulin‐like growth factor‐1 levels and inhibits its effects in the ventral prostate in mice

  2006cites this paper
• Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cells

  2005cites this paper
• Mechanism of Castration-induced Apoptosis of Ventral Prostate in Rat

  2005cites this paper
• Androgen- and Estrogen-Dependent Regulation of Insulin-Degrading Enzyme in Subcellular Fractions of Rat Prostate and Uterus

  2005cites this paper
• Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate.

  2005cites this paper
• [Protocadherin-PC discovery and its implication in prostate cancer progression].

  2005cites this paper
• Rapid Apoptosis Induction by IGFBP-3 Involves an Insulin-like Growth Factor-independent Nucleomitochondrial Translocation of RXRα/Nur77*

  2005cites this paper
• Characterization of a Novel Positive Transcription Regulatory Element That Differentially Regulates the Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Gene in Senescent Cells*

  2005cites this paper
• Insulin-like growth factor binding protein 2: an androgen-dependent predictor of prostate cancer survival.

  2005cites this paper
• Combination Therapy of Insulin-Like Growth Factor Binding Protein-3 and Retinoid X Receptor Ligands Synergize on Prostate Cancer Cell Apoptosis In vitro and In vivo

  2005cites this paper
• Quantitative Proteomic Analysis of Proteins Released by Neoplastic Prostate Epithelium

  2004cites this paper
• Reduction of rat prostate weight by combined quercetin-finasteride treatment is associated with cell cycle deregulation.

  2004cites this paper
• Antisense Therapy: Current Status in Prostate Cancer and Other Malignancies

  2004cites this paper
• Morphological changes and oxidative stress in rat prostate exposed to a non-carcinogenic dose of cadmium.

  2004cites this paper
• Antisense approaches in prostate cancer

  2004cites this paper
• Paradoxical Actions of Endogenous and Exogenous Insulin-like Growth Factor-binding Protein-5 Revealed by RNA Interference Analysis*

  2004cites this paper
• Chemoprevention of Prostate Cancer

  2004cites this paper
• Cancer Chemoprevention

  2004cites this paper
• Insulin-like Growth Factor-binding Protein-5 Inhibits the Growth of Human Breast Cancer Cells in Vitro and in Vivo*

  2003cites this paper
• Identification of androgen-responsive genes in the rat ventral prostate by complementary deoxyribonucleic acid subtraction and microarray.

  2003cites this paper
• Prostatic androgen repressed message‐1 (PARM‐1) may play a role in prostatic cell immortalisation

  2003cites this paper
• Antisense targets to enhance hormone and cytotoxic therapies in advanced prostate cancer.

  2003cites this paper
• Genital Skin Fibroblasts (GF) of Patients with Androgen Insensitivity Syndrome Express Higher Insulin-Like Growth Factor Binding Protein (IGFBP)-2, -3 and -5 than GF of Normally Virilized Males

  2003cites this paper
• Insulin-like Growth Factor-I Inhibits Transcriptional Responses of Transforming Growth Factor-β by Phosphatidylinositol 3-Kinase/Akt-dependent Suppression of the Activation of Smad3 but Not Smad2*

  2003cites this paper
• Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.

  2003cites this paper
• Clusterin and IGFBPs as Antisense Targets in Prostate Cancer

  2003cites this paper
• Induction of apoptosis in rat ventral prostate by finasteride is associated with alteration in MAP kinase pathways and Bcl-2 related family of proteins.

  2002cites this paper
• Cellular actions of the insulin-like growth factor binding proteins.

  2002cites this paper
• Differential expression of CCAAT/enhancer-binding protein-delta (c/EBPdelta) in rat androgen-dependent tissues and human prostate cancer.

  2001cites this paper
• Insulin-like growth factors and prostate cancer.

  2001cites this paper
• Regulation of the gap junction connexin 43 gene by androgens in the prostate.

  2001cites this paper
• Insulin-like growth factor I and prostate cancer.

  2001cites this paper
• Regulation of proliferation of prostate epithelial cells by 1,25-dihydroxyvitamin D3 is accompanied by an increase in insulin-like growth factor binding protein-3.

  2001cites this paper
• Novel therapeutic strategy for advanced prostate cancer using antisense oligodeoxynucleotides targeting anti‐apoptotic genes upregulated after androgen withdrawal to delay androgen‐independent progression and enhance chemosensitivity

  2001cites this paper
• Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system

  2001cites this paper
• Induction of apoptosis in mammary gland by a pure anti-estrogen ICI 182780

  2001cites this paper
• Co-administration of finasteride and the pure anti-oestrogen ICI 182,780 act synergistically in modulating the IGF system in rat prostate.

  2001influential citation
• Decreased expression of IGF-II and its binding protein, IGF-binding protein-2, in genital skin fibroblasts of patients with complete androgen insensitivity syndrome compared with normally virilized males.

  2001cites this paper
• Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?

  2001cites this paper
• In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).

  2001cites this paper
• Protector or Promoter ? Insulin-like Growth Factor-binding Protein 2 in Tumorigenesis : Updated

  2001cites this paper
• Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.

  2001cites this paper
• Circulating Insulin-like Growth Factor-I and Benign Prostatic Hyperplasia - A Prospective Study

  2001cites this paper
• Insulin-like growth factors and prostate cancer

  2001cites this paper
• Other novel agents: Rationale and current status as chemopreventive agents.

  2001cites this paper
• Roles of insulin-like growth factor-I (IGF-I) and IGF-I binding protein-2 (IGFBP2) and -5 (IGFBP5) in developing chick limbs.

  2001cites this paper
• Insulin-like Growth Factors and Prostate Cancer

  2001cites this paper
• Systemic treatment with epidermal growth factor but not insulin-like growth factor I decreases the involution of the prostate in castrated rats

  2000cites this paper
• Insulin-like growth factor physiology and cancer risk.

  2000cites this paper
• Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.

  2000cites this paper
• Genes upregulated during castration‐induced rat prostatic apoptosis: cloning and characterization of new cDNAs

  2000cites this paper
• Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium.

  2000cites this paper
• Association of castration-dependent early induction of c-myc expression with a cell proliferation of the ventral prostate gland in rat

  2000cites this paper
• Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.

  2000cites this paper
• Does the GH-IGF axis play a role in cancer pathogenesis?

  2000cites this paper
• Expression of the insulin‐like growth factor system and cancer progression in hormone‐treated prostate cancer patients

  2000cites this paper
• Prostatic involution in men taking finasteride is associated with elevated levels of insulin‐like growth factor‐binding proteins (IGFBPs)‐2, ‐4, and ‐5

  2000cites this paper
• Genetics, chemistry, and function of the IGF/IGFBP system

  2000cites this paper
• Cell kinetics and differentiation after hormonal‐induced prostatic hyperplasia in the dog

  2000cites this paper
• Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy.

  2000cites this paper
• The question of a link between insulin-like growth factor physiology and neoplasia.

  2000cites this paper
• Estrogens and prostatic disease. International Prostate Health Council Study Group.

  2000cites this paper
• Insulin-like Growth Factor-binding Protein-3 Modulates Expression of Bax and Bcl-2 and Potentiates p53-independent Radiation-induced Apoptosis in Human Breast Cancer Cells*

  2000cites this paper
• Insulin-like growth factor physiology and neoplasia.

  2000cites this paper
• Novel aspects of the insulin-like growth factor binding proteins.

  1999cites this paper
• Vitamin D analogue EB1089-induced prostate regression is associated with increased gene expression of insulin-like growth factor binding proteins.

  1999cites this paper
• mRNA and protein localization of the IGF system during mouse embryonic development in areas with apoptosis.

  1999cites this paper
• Circulating IGF-I: New Perspectives for a New Century.

  1999cites this paper
• Bicalutamide (Casodex)-induced prostate regression involves increased expression of genes encoding insulin-like growth factor binding proteins.

  1999cites this paper
• Growth Factors, Apoptosis, and Survival of Mammary Epithelial Cells

  1999cites this paper